No Data
RheinBio: 2024 Annual Report Summary
RheinBio: 2024 Annual Report
Guilin Layn Natural Ingredients Corp. (002166.SZ): For the fiscal year 2024, net income attributable to the parent company is expected to be 0.163 billion yuan, proposing a 1 yuan dividend per share.
Gelonghui, March 27, Guilin Layn Natural Ingredients Corp. (002166.SZ) announced its annual report for 2024, achieving revenue of 1.772 billion yuan in 2024, a year-on-year increase of 18.60%; net income attributable to the shareholders of the listed company was 0.163 billion yuan, a year-on-year increase of 97.56%; net income attributable to the shareholders of the listed company, excluding non-recurring gains and losses, was 0.151 billion yuan, a year-on-year increase of 634.19%; basic EPS was 0.22 yuan; a cash dividend of 1 yuan (including tax) for every 10 shares is proposed to be distributed to all shareholders.
Is Guilin Layn Natural Ingredients (SZSE:002166) Using Too Much Debt?
Layn Natural Ingredients' Sweetener Passes US FDA's Quality, Safety Review
Guilin Layn Natural Ingredients Corp. (002166.SZ): The relevant Business has not yet been integrated into the DeepSeek model.
On February 12, Glory Financial reported that Guilin Layn Natural Ingredients Corp. (002166.SZ) stated on the investor interaction platform that the company is continuously paying attention to DeepSeek and its application scenarios, and so far, the related business has not yet been integrated with the DeepSeek model. For manufacturing enterprises, Intelligent Manufacturing is an important direction for upgrading business operations. Currently, the company's Guilin comprehensive extraction production base and synthetic biology production workshop all have automated intelligent extraction production lines, achieving precise control and optimization of the production process through intelligent terminals, reducing reliance on manual labor and errors, cutting costs and increasing efficiency, thereby improving production and operational efficiency.
Guilin Layn Natural Ingredients (SZSE:002166) Could Be Struggling To Allocate Capital
